A detailed history of Captrust Financial Advisors transactions in Ironwood Pharmaceuticals Inc stock. As of the latest transaction made, Captrust Financial Advisors holds 26,741 shares of IRWD stock, worth $98,139. This represents 0.0% of its overall portfolio holdings.

Number of Shares
26,741
Previous 27,618 3.18%
Holding current value
$98,139
Previous $180,000 39.44%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$3.93 - $7.04 $3,446 - $6,174
-877 Reduced 3.18%
26,741 $109,000
Q2 2024

Aug 14, 2024

BUY
$5.58 - $8.61 $4,843 - $7,473
868 Added 3.24%
27,618 $180,000
Q1 2024

May 15, 2024

SELL
$8.32 - $15.45 $25,068 - $46,550
-3,013 Reduced 10.12%
26,750 $232,000
Q4 2023

Feb 14, 2024

BUY
$8.79 - $11.51 $261,616 - $342,572
29,763 New
29,763 $340,000
Q2 2022

Aug 23, 2022

SELL
$11.05 - $12.72 $16,552 - $19,054
-1,498 Reduced 18.3%
6,690 $77,000
Q2 2022

Aug 16, 2022

BUY
$11.05 - $12.72 $76,830 - $88,442
6,953 Added 563.0%
8,188 $94,000
Q1 2022

May 16, 2022

BUY
$10.61 - $12.88 $1,506 - $1,828
142 Added 12.99%
1,235 $16,000
Q4 2021

Feb 14, 2022

BUY
$10.86 - $13.95 $4,278 - $5,496
394 Added 56.37%
1,093 $13,000
Q3 2021

Nov 16, 2021

SELL
$11.92 - $13.92 $631 - $737
-53 Reduced 7.05%
699 $9,000
Q2 2021

Aug 16, 2021

SELL
$10.16 - $13.11 $30,175 - $38,936
-2,970 Reduced 79.8%
752 $10,000
Q1 2021

May 17, 2021

BUY
$9.04 - $11.86 $33,176 - $43,526
3,670 Added 7057.69%
3,722 $42,000
Q4 2020

Feb 16, 2021

BUY
$9.05 - $12.2 $470 - $634
52 New
52 $1,000

Others Institutions Holding IRWD

About IRONWOOD PHARMACEUTICALS INC


  • Ticker IRWD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 153,231,008
  • Market Cap $562M
  • Description
  • Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...
More about IRWD
Track This Portfolio

Track Captrust Financial Advisors Portfolio

Follow Captrust Financial Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Captrust Financial Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Captrust Financial Advisors with notifications on news.